Optima Medical Innovations Corp. (OMIC)
Feb 21, 2025 - OMIC was delisted (reason: acquired by Deerfield)
20.01
0.00 (0.00%)
Inactive · Last trade price
on Feb 20, 2025
Company Description
Optima Medical Innovations Corp. delivers pathways to innovative, science-based health, and wellness solutions.
It offers solution for pain relief, wellness, and cancer therapy. The company was formerly known as Tree of Knowledge International Corp. and changed its name to Optima Medical Innovations Corp. in November 2021.
Optima Medical Innovations Corp. is based in Toronto, Canada.
Optima Medical Innovations Corp.
| Country | Canada |
| Founded | 2016 |
| IPO Date | May 27, 2021 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 255 |
| CEO | Ali Sakhavati |
Contact Details
Address: 209-5460 Yonge Street Toronto, California M2N 6K7 Canada | |
| Phone | 858 333 7830 |
| Website | tokicorp.com |
Stock Details
| Ticker Symbol | OMIC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $22.00 |
| CIK Code | 0001850906 |
| CUSIP Number | 82933R100 |
| ISIN Number | US82933R1005 |
| Employer ID | 81-2948451 |
| SIC Code | 7370 |
Key Executives
| Name | Position |
|---|---|
| Andrew Spaventa | Founder, Chief Executive Officer, President and Chairperson of the Board |
| Dr. David L. Barker Ph.D. | Founder, Member of Scientific Advisory Board and Independent Director |
| Dr. Eli N. Glezer Ph.D. | Founder, Chief Scientific Officer and Chair of Scientific Advisory Board |
| Dalen Meeter | Chief Financial Officer |
| Dr. Jyotsna Ghai Ph.D. | Chief Operating Officer |
| Eric Stier | Senior Vice President, General Counsel and Secretary |
| Vincent Brancaccio | Head of Human Resources |
| Jorge Velarde Jr., MBA | Chief Business Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 21, 2025 | EFFECT | Notice of Effectiveness |
| Feb 21, 2025 | 25-NSE | Filing |
| Feb 21, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Feb 21, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Feb 21, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Feb 21, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Feb 21, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Feb 21, 2025 | POS AM | Post-Effective amendments for registration statement |
| Feb 19, 2025 | 8-K | Current Report |
| Feb 13, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |